Oral anticancer medicine interventions: A cross-sectional study in French community pharmacies.
Fiche publication
Date publication
mars 2024
Journal
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Auteurs
Membres identifiés du Cancéropôle Est :
Dr PEYRON Christine
Tous les auteurs :
Macé F, Peyron C, Cransac A, Pistre P, Boulin M
Lien Pubmed
Résumé
The increasing number of oral anticancer medicines (OAMs) dispensed in community pharmacies and the associated challenges (misuse, management of side effects) give the community pharmacist (CP) a major role in the pharmacotherapeutic management of cancer patients. In France, as a response to these challenges, cancer outpatients can schedule a meeting with their CP to ensure the safe and effective use of OAMs. The objectives of this study were to evaluate the perspectives of these interventions regarding their implementation and the opinion of French CPs.
Mots clés
Oral anticancer medicines, community pharmacy, implementation, pharmaceutical intervention
Référence
J Oncol Pharm Pract. 2024 03 7;:10781552241237743